Promising effects of 3rd line cyclophosphamide, adriamycin and vincristine (CAV) and 4th line ifosfamide and carboplatin chemotherapy in refractory small cell lung cancer

Third and fourth line chemotherapy agents are not helpful in the setting of extensive stage small cell lung cancer (SCLC). We describe the case of a 43-year-old Korean patient with T4N3M1b extensive stage SCLC who responded remarkably well to treatment and experienced a prolonged progression-free su...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Thorac Cancer
Autori principali: Jung, Sang Ok, Kim, Sun Young, Kim, Ju-Ock, Jung, Sung Soo, Park, Hee Sun, Moon, Jae Young, Kim, Sung Min, Lee, Jeong Eun
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Ltd 2015
Soggetti:
Case Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4567014/
https://ncbi.nlm.nih.gov/pubmed/26445616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12198
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi